Tissue Transglutaminase Expression Associates With Progression of Multiple Sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 24, 2020
- Accepted in final form February 22, 2021
- First Published April 27, 2021.
Author Disclosures
- Claudia Sestito, PhD (c.sestito{at}amsterdamumc.nl),
- Cyra E. Leurs, MD, PhD* (c.leurs{at}vumc.nl),
- Martijn D. Steenwijk, PhD* (m.steenwijk{at}amsterdamumc.nl),
- John J.P. Brevé, BASc,
- Jos W.R. Twisk, PhD (jwr.twisk{at}amsterdamumc.nl),
- Micha M.M. Wilhelmus, PhD (m.wilhelmus{at}amsterdamumc.nl),
- Benjamin Drukarch, MD, PhD (b.drukarch{at}amsterdamumc.nl),
- Charlotte E. Teunissen, PhD (c.teunissen{at}amsterdamumc.nl),
- Anne-Marie van Dam, PhD† and
- Joep Killestein, MD, PhD† (j.killestein{at}amsterdamumc.nl)
- Claudia Sestito, PhD (c.sestito{at}amsterdamumc.nl),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Cyra E. Leurs, MD, PhD* (c.leurs{at}vumc.nl),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Stichting MS Research (GRANT Number: 14-538e)
NONE
NONE
NONE
NONE
NONE
NONE
- Martijn D. Steenwijk, PhD* (m.steenwijk{at}amsterdamumc.nl),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- John J.P. Brevé, BASc,
- Jos W.R. Twisk, PhD (jwr.twisk{at}amsterdamumc.nl),
- Micha M.M. Wilhelmus, PhD (m.wilhelmus{at}amsterdamumc.nl),
- Benjamin Drukarch, MD, PhD (b.drukarch{at}amsterdamumc.nl),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Charlotte E. Teunissen, PhD (c.teunissen{at}amsterdamumc.nl),
Roche.
NONE
Roche, payment to my institute.
CCLM special issue editor (2018-2019). Alz Res Ther Associate Editor (since 2020).
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
ZonMW, JPND
NONE
Weston Brain Institute, Alzheimer Nederland, International Alzheimer Association.
NONE
NONE
NONE
NONE
NONE
NONE
- Anne-Marie van Dam, PhD† and
non-profit entity: Dutch MS Research Foundation
NONE
NONE
Neuropharmacology, editorial board member, 9 years Brain, Behavour and Immunity, editorial board member, 6 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Joep Killestein, MD, PhD† (j.killestein{at}amsterdamumc.nl)
Steering committees Roche and Biogen trials
NONE
Speaker honoraria Biogen, Novartis, TEVA, Merck, Roche
Editor of the official scientific journal of the Dutch Society of Neurology, the Dutch Society of Neurosurgeons and the Society of Flemish Neurologists (Tijdschrift voor Neurologie en Neurochirurgie). Editorial board MS Journal Editorial board Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I have been involved in clinical trials of several companies that market drugs for MS. The past two years Biogen and Roche sponsored trials.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From Amsterdam UMC, Vrije Universiteit, Amsterdam Neuroscience, MS Center Amsterdam, Department of Anatomy and Neurosciences (C.S., M.D.S., J.J.P.B., M.M.M.W., B.D., A.-M.v.D.), Department of Neurology (C.E.L., J.K.), Department of Epidemiology and Biostatistics (J.W.R.T.), and Department of Clinical Chemistry (C.E.T.), Amsterdam, the Netherlands.
- Correspondence
Dr. van Dam amw.vandam{at}amsterdamumc.nl
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.